0001600132-16-000083.txt : 20160621 0001600132-16-000083.hdr.sgml : 20160621 20160621181052 ACCESSION NUMBER: 0001600132-16-000083 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160617 FILED AS OF DATE: 20160621 DATE AS OF CHANGE: 20160621 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc. CENTRAL INDEX KEY: 0001600132 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473116175 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-574-4770 MAIL ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: Bellerophon Therapeutics LLC DATE OF NAME CHANGE: 20140213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Luehring Jens CENTRAL INDEX KEY: 0001631764 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36845 FILM NUMBER: 161725220 MAIL ADDRESS: STREET 1: C/O LINDE NORTH AMERICA INC. STREET 2: 575 MOUNTAIN AVENUE CITY: MURRAY HILL STATE: NJ ZIP: 07974 4 1 wf-form4_146654703894746.xml FORM 4 X0306 4 2016-06-17 0 0001600132 Bellerophon Therapeutics, Inc. BLPH 0001631764 Luehring Jens C/O LINDE NORTH AMERICA, INC. 200 SOMERSET CORPORATE BLV, SUITE 7000 BRIDGEWATER NJ 08807 1 0 1 0 Stock Option (right to buy) 1.94 2016-06-17 4 A 0 10000 0 A 2026-06-16 Common Stock 10000.0 10000 D This option was granted on June 17, 2016. This option vests in three equal annual installments over a three-year period from the date of grant. /s/ Jens Luehring 2016-06-21